Glooko
PrivateLast Round
Series F
Oct 10, 2024
Est. Valuation
$420.88M
Total Funding Raised
$201M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Glooko is a healthtech company that provides a remote patient-monitoring and diabetes management platform designed to integrate data from diabetes devices and fitness wearables to provide actionable insights for healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Health IoT, Healthcare Analytics, Medical Devices, Patient Engagement
Business Model
B2B2C
Customer Profile
Subscription SaaS, Data as a Service, Revenue Share, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glooko Comparables
Compare Glooko with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tidepool | 78% | |
| Glytec | 77% | |
| Welldoc | 76% |
Glooko Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Oct 10, 2024 | ||||
| Series D | Mar 16, 2021 | ||||
| Series C | Jun 27, 2017 | ||||
| Series C | Sep 13, 2016 | ||||
| Series B | Mar 17, 2015 | ||||
Series A Extension | Jan 8, 2014 |
Key People
Founding team and executive leadership
Glooko Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Georgian | Series D, Series C, Series F |
| Lifeforce Capital | Series A Extension |
| Health Catalyst Capital Management | Series D |
| Realization Capital Partners | Series F |
| Social Capital | Series B, Series C, Series A, Seed, Series A Extension |
| Samsung NEXT Ventures | Series C |
| Cambrian | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Attending the 2026 AACE Annual Meeting in Las Vegas.
- Apr 14, 2026
Integrated digital health solution with NextGen's EHR system.
Recent news
Latest coverage and updates
- launchesSep 1, 2026
Glooko, Inc. launched GestationalCare module for Diabetes in pregnancy on Sep 1st '26.
- launchesSep 1, 2026
Glooko, Inc. launched GestationalCare on Sep 1st '26.
- attends_eventJul 29, 2026
Glooko, Inc. will attend event 2026 Annual Meeting on Aug 7th '26.
Glooko Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Glooko's valuation, stock price, and market status.
Is Glooko a public or private company?
Glooko is a private company.
What is the current stock price of Glooko?
Glooko is a private company with no public stock price. No recent secondary market data is available.
How much is Glooko worth (valuation)?
Valuation information for Glooko is not publicly available.
Can I buy Glooko stock?
Glooko shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Glooko's last funding round?
Glooko's most recent funding round was Series F on October 10, 2024.
Who are the main investors in Glooko?
Key investors in Glooko include Georgian, Health Catalyst Capital Management, Social Capital, Samsung Venture Investment, Canaan Partners.
Will Glooko IPO soon?
No public IPO plans have been announced for Glooko.
How can I track Glooko secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Glooko's secondary market activity and sign up for updates.